Epigenetic patterns of two gene promoters (TNF-α and PON) in stroke considering obesity condition and dietary intake

Journal of Physiology and Biochemistry

Volumn 70, Issue 2, 2014, Pages 603-614

  Gomez Uriz A M ^a   Goyenechea, E ^c   Campion J ^a,b   De Arce, A ^b,c,d   Martinez, M T ^b,c,d,e   Puchau, B ^a   Milagro, F I ^a,b   Abete, I ^c   Martinez J A ^a,b   Lopez De Munain, A ^b,c,d,e  

^a UNIVERSITY OF NAVARRA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^d HOSPITAL DONOSTIA   (Spain)

^e UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Biomarkers; Body composition; Cerebrovascular accident; DNA methylation; Food habits; Histone modifications

Indexed keywords

ARYLDIALKYLPHOSPHATASE; TUMOR NECROSIS FACTOR ALPHA; PRIMER DNA;

AGED; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CALORIC INTAKE; CEREBROVASCULAR ACCIDENT; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DIETARY INTAKE; DISEASE PREDISPOSITION; DNA ISOLATION; DNA METHYLATION; EPIGENETICS; FAT INTAKE; FEMALE; HISTONE MODIFICATION; HUMAN; MALE; OBESITY; PROMOTER REGION; STROKE PATIENT; WAIST CIRCUMFERENCE; DIET; GENETIC EPIGENESIS; GENETICS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION;

AGED; ARYLDIALKYLPHOSPHATASE; BASE SEQUENCE; DIET; DNA METHYLATION; DNA PRIMERS; EPIGENESIS, GENETIC; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; STROKE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84904619199     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-014-0316-5     Document Type: Article

References (51)

1. Alcacera MA, Marques-Lopes I, Fajo-Pascual M, Foncillas JP, Carmona-Torre F, Martinez-Gonzalez MA (2008) Alcoholic beverage preference and dietary pattern in Spanish university graduates: the SUN cohort study. Eur J Clin Nutr 62:1178-1186
2. Anderson CD, Biffi A, Rost NS, Cortellini L, Furie KL, Rosand J (2010) Chromosome 9p21 in ischemic stroke. Population structure and meta-analysis. Stroke 41:1123-1131
3. Barrachina M, Ferrer I (2009) DNA methylation of Alzheimer disease and tauopathy-related genes in postmortem brain. J Neuropathol Exp Neurol 68:880-891
4. Bendavid C, Dubourg C, Pasquier L, Gicquel I, Le Gallou S, Mottier S et al (2007) MLPA screening reveals novel subtelomeric rearrangements in holoprosencephaly. Hum Mutat 28:1189-1197 (Pubitemid 350250383)
5. Bodenant M, Kuulasmaa K, Wagner A, Kee F, Palmieri L, Ferrario MM et al (2011) Measures of abdominal adiposity and the risk of stroke: the MOnica Risk, Genetics, Archiving and Monograph (MORGAM) study. Stroke 42:2872-2877
6. Campión J, Milagro F, Martínez JA (2010) Epigenetics and obesity. Prog Mol Biol Transl Sci 94:291-347
7. Campión J, Milagro FI, Goyenechea E, Martínez JÁ (2009) TNF-alpha promoter methylation as a predictive biomarker for weight-loss response. Obesity 17:1293-1297
8. Chmurzynska A (2010) Fetal programming: link between early nutrition, DNA methylation, and complex diseases. Nutr Rev 68:87-98
9. Chomistek AK, Manson JE, Stefanick ML, Lu B, Sands-Lincoln M, Going SB, Garcia L, Allison MA, Sims ST, LaMonte MJ, Johnson KC, Eaton CB (2013) Relationship of sedentary behavior and physical activity to incident cardiovascular disease: results from theWomen's Health Initiative. J Am Coll Cardiol 61:2346-2354
10. Curioni C, André C, Veras R. (2006) Weight reduction for primary prevention of stroke in adults with overweight or obesity. Cochrane Database Syst Rev 18: CD006062
11. Docherty SJ, Davis OS, Haworth CM, Plomin R, Mill J (2009) Bisulfite-based epityping on pooled genomic DNA provides an accurate estimate of average group DNA methylation. Epigenetics Chromatin 2:3
12. El Gazzar M, Yoza BK, Hu JY, Cousart SL, McCall CE (2010) Epigenetic silencing of tumor necrosis factor alpha during endotoxin tolerance. J Biol Chem 282:26857-26864 (Pubitemid 47501896)
13. Garden GA (2013) Epigenetics and the modulation of neuroinflammation. Neurotherapeutics 10:782-788
14. Gorelick PB, Sacco RL, Smith DB, Alberts M, Mustone-Alexander L, Rader D et al (1999) Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA 281:1112-1120 (Pubitemid 29155889)
15. Goyenechea E, Parra D, Crujeiras AB, Abete I, Martínez JA (2009) A nutrigenomic inflammation-related PBMC-based approach to predict the weight-loss regain in obese subjects. Ann Nutr Metab 54:43-51
16. Goyenechea E, Parra D, Martínez JA (2007) Impact of interleukin 6-174G>C polymorphism on obesity-relatedmetabolic disorders in people with excess in body weight. Metabolism 56:1643-1648 (Pubitemid 350060931)
17. Hermsdorf HH, Mansego ML, Campión J, Milagro FI, Zulet MA, Martínez JA (2013) TNF-alpha promoter methylation in peripheral white blood cells: relationship with circulating TNFα, truncal fat and n-6 PUFA intake in young women. Cytokine 64:265-271
18. Hwang JY, Aromolaran KA, Zukin RS (2013) Epigenetic mechanisms in stroke and epilepsy. Neuropsychopharmacology 38:167-182
19. Kirsch-Volders M, Bonassi S, Herceg Z, Hirvonen A, Möller L, Phillips DH (2010) Gender-related differences in response to mutagens and carcinogens. Mutagenesis 25:213-221
20. Kotani K, Sakane N, Sano Y, Tsuzaki K, Matsuoka Y, Egawa K et al (2009) Changes on the physiological lactonase activity of serum paraoxonase 1 by a diet intervention for weight loss in healthy overweight and obese women. J Clin Biochem Nutr 45:329-334
21. Kumon Y, Nakauchi Y, Suehiro T, Shiinoki T, Tanimoto N, InoueMet al (2002) Proinflammatory cytokines but not acute phase serum amyloid A or C-reactive protein, downregulate paraoxonase 1 (PON1) expression by HepG2 cells. Amyloid 9:160-164 (Pubitemid 35205205)
22. Laborde CM, Mourino-Alvarez L, Akerstrom F, Padial LR, Vivanco F, Gil-Dones F, Barderas MG (2012) Potential blood biomarkers for stroke. Expert Rev Proteomics 9:437-449
23. Lachin JM (2005) A review of methods for futility stopping based on conditional power. Stat Med 24:2747-2764
24. Lai CQ, Parnell LD, Troen AM, Shen J, Caouette H, Warodomwichit D et al (2010) MAT1A variants are associated with hypertension, stroke, and markers of DNA damage and are modulated by plasma vitamin B-6 and folate. Am J Clin Nutr 91:1377-1386
25. Laird PW (2003) The power and the promise of DNA methylation markers. Nat Rev 3:253-266
26. Lanktree MB, Dichgans M, Hegele RA (2010) Advances in genomic analysis of stroke: what have we learned and where are we headed? Stroke 41:825-832
27. Lv L, Tang YP, Han X,Wang X, Dong Q (2011) Therapeutic application of histone deacetylase inhibitors for stroke. Cent Nerv Syst Agents Med Chem 11:138-149
28. Martínez-González MA, Sanchez-Villegas A, Faulin FJ (2006) Bioestadística amigable, 2a Edit. Díaz-Santos
29. Martin-Moreno JM, Boyle P, Gorgojo L, Maisonneuve P, Fernandez-Rodriguez JC, Salvini S et al (1993) Development and validation of a food frequency questionnaire in Spain. Int J Epidemiol 22:512-519 (Pubitemid 23208950)
30. Mathew OP, Ranganna K, Yatsu FM (2010) Butyrate, an HDAC inhibitor, stimulates interplay between different post-translational modifications of histone H3 and differently alters G1-specific cell cycle proteins in vascular smooth muscle cells. Biomed Pharmacother 64:733-740
31. Miao F, Smith DD, Zhang L, Min A, Feng W, Natarajan R (2008) Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes. Diabetes 57:3189-3198
32. Miao F, Wu X, Zhang L, Yuan YC, Riggs AD, Natarajan R (2007) Genome-wide analysis of histone lysine methylation variations caused by diabetic conditions in human monocytes. J Biol Chem 282:13854-13863 (Pubitemid 47100501)
33. Micha R, Mozaffarian D (2010) Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids 45:893-905
34. Moreiras O, Carvajal A, Cabrera L (2009) Tablas de composición de alimentos [Food composition tables]. Pirámide, Madrid
35. Okamura M, Inagaki T, Tanaka T, Sakai J (2010) Role of histone methylation and demethylation in adipogenesis and obesity. Organogenesis 6:24-32
36. Pereira TV, Rudnicki M, Franco RF, Pereira AC, Krieger JE (2007) Effect of the G-308A polymorphism of the tumor necrosis factor alpha gene on the risk of ischemic heart disease and ischemic stroke: a meta-analysis. Am Heart J 153:821-830 (Pubitemid 46602156)
37. Pérez S, Parra MD, Martínez de Morentin B, Rodríguez MC, Martínez JA (2005) Evaluación de la variabilidad intraindividual de la medida de composición corporal mediante bioimpedancia en voluntarias sanas y su relación con el índice de masa corporal y el pliegue tricipital. Enferm Clin 15:307-314
38. Popa C, van Tits LJ, Barrera P, Lemmers HL, van den Hoogen FH, van Riel PL et al (2009) Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients. Ann Rheum Dis 68:868-872
39. Puchau B, Zulet MA, de Echávarri AG, Hermsdorff HH, Martínez JA (2010) Dietary total antioxidant capacity is negatively associated with some metabolic syndrome features in healthy young adults. Nutrition 26:534-541
40. Qureshi IA, Mehler MF (2010) Emerging role of epigenetics in stroke: part 1: DNA methylation and chromatin modifications. Arch Neurol 67:1316-1322
41. Rando OJ, Verstrepen KJ (2007) Timescales of genetic and epigenetic inheritance. Cell 128:655-668
42. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM et al (2011) Heart disease and stroke statistic update: a report from the American Heart Association. Circulation 123:240
43. Ross OA, Meschia JF (2009) Genetics of ischemic stroke: inheritance of a sporadic disorder. Curr Neurol Neurosci Rep 9:19-27
44. Seres I, Bajnok L,HarangiM, Sztanek F, Koncsos P, ParaghG (2010) Alteration of PON1 activity in adult and childhood obesity and its relation to adipokine levels. Adv Exp Med Biol 660:129-142
45. Shin BS, Oh SY, Kim YS, Kim KW (2008) The paraoxonase gene polymorphism in stroke patients and lipid profile. Acta Neurol Scand 117:237-243
46. Timpson NJ, Harbord R, Davey Smith G, Zacho J, Tybjaerg-Hansen A, Nordestgaard BG (2009) Does greater adiposity increase blood pressure and hypertension risk?: Mendelian randomization using the FTO/MC4R genotype. Hypertension 54:84-90
47. Urdinguio RG, Sanchez-Mut JV, EstellerM(2009) Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol 8:1056-1072
48. Wang X, Cheng S, Brophy VH, Erlich HA, Mannhalter C, Berger K et al (2009) A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients. Stroke 40:683-695
49. Wang Z, Leng Y, Tsai LK, Leeds P, Chuang DM (2011) Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition. J Cereb Blood Flow Metab 31:52-57
50. Yamada N, Nishida Y, Tsutsumida H, Goto M, Higashi M, Nomoto M et al (2010) Expression of MUC5AC, an early marker of pancreatobiliary cancer, is regulated by DNA methylation in the distal promoter region in cancer cells. J Hepatobiliary Pancreat Sci 17:844-854
51. Zulet MA, Puchau B, Hermsdorff HH, Navarro C, Martínez JA (2009) Dietary selenium intake is negatively associated with serum sialic acid and metabolic syndrome features in healthy young adults. Nutr Re 29:41-48